---
schema_version: "secwatch.filing_event.v1"
accession: "0001279569-25-000503"
form_type: "8-K"
ticker: "CWBHF"
cik: "0001750155"
company_name: "Charlotte's Web Holdings, Inc."
filed_at: "2025-05-14T23:59:59+00:00"
generated_at: "2026-05-21T09:18:07.423006+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Charlotte’s Web posts Q1 2025 revenue of $12.3M, first YoY growth since 2021; net loss narrows to $6.2M

## Summary
- Revenue $12.3M +1.1% YoY (first growth since Q2 2021); SG&A down 24.2%.
- Net loss $6.2M ($0.04/sh) vs $9.7M; Adj. EBITDA -$2.8M vs -$3.9M.
- Ended MLB deal, cutting >$18M in future cash outlays over 3 years.
- DeFloria JV got FDA clearance for Phase 2 trial of AJA001 for autism irritability.
- Whole Foods Market to roll out 3 topical isolates in 400+ stores starting June 2025.

## SEC filing metadata
- accession: 0001279569-25-000503
- form_type: 8-K
- ticker: CWBHF
- cik: 0001750155
- company_name: Charlotte's Web Holdings, Inc.
- filed_at: 2025-05-14T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1750155/000127956925000503/0001279569-25-000503-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1750155/000127956925000503/form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001279569-25-000503
- JSON: https://secwatch.observer/filing/0001279569-25-000503.json
- Plain text: https://secwatch.observer/filing/0001279569-25-000503.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.